Are two doses of misoprostol after mifepristone for early abortion better than one?

被引:20
作者
Coyaji, K.
Krishna, U.
Ambardekar, S.
Bracken, H.
Raote, V.
Mandlekar, A.
Winikoff, B.
机构
[1] Gynuity Hlth Projects, New York, NY 10010 USA
[2] KEM Hosp, Dept Obstet & Gynaecol, Pune, Maharashtra, India
[3] Larsen & Toubro Hlth Ctr, Bombay, Maharashtra, India
关键词
India; medical abortion; mifepristone; misoprostol; EARLY MEDICAL ABORTION; EARLY-PREGNANCY TERMINATION; RANDOMIZED-TRIAL; VAGINAL MISOPROSTOL; UNITED-STATES; EFFICACY; ACCEPTABILITY; WOMEN; GESTATION; REGIMENS;
D O I
10.1111/j.1471-0528.2006.01208.x
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective The objective of this study was to determine if a repeat dose of misoprostol following mifepristone or a single dose of misoprostol increases the efficacy of medical termination of pregnancy. Design Randomised, placebo controlled trial. Setting K.E.M. Hospital, Pune, India, and the Health Centre, Larsen and Toubro Limited, Mumbai, India. Sample A total of 300 women seeking an abortion with amenorrhoea of 8 weeks or less. Methods Women were randomised to receive one or two doses of 400 microgram oral misoprostol at the clinic 48 hours after administration of 200 mg mifepristone. Main outcome measure Complete abortion without surgical intervention. Results The repeat administration of misoprostol 400 microgram improved the complete abortion rate from 86 to 92% and significantly reduced the rate of continuing pregnancy from 7 to 1%. Almost all the women who were administered the additional dose of misoprostol were either very satisfied (58%) or satisfied (37%) with the method. Conclusion While an additional oral dose of 400 microgram misoprostol did not significantly increase the rate of complete abortion without surgical intervention, the additional dose did significantly reduce the rate of continuing pregnancies without compromising the acceptability and ease of use of the method.
引用
收藏
页码:271 / 278
页数:8
相关论文
共 50 条
  • [21] Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol
    Reeves, Matthew F.
    Monmaney, Jessica A.
    Creinin, Mitchell D.
    CONTRACEPTION, 2016, 93 (02) : 119 - 125
  • [22] Comparison or oral versus vaginal misoprostol & continued use of misoprostol after mifepristone for early medical abortion
    Mittal, S
    Agarwal, S
    Kumar, S
    Batra, A
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2005, 122 (02) : 132 - 136
  • [23] Regimens of misoprostol with mifepristone for early medical abortion: a randomised trial
    Shannon, C.
    Wiebe, E.
    Jacot, F.
    Guilbert, E.
    Dunn, S.
    Sheldon, W. R.
    Winikoff, B.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2006, 113 (06) : 621 - 628
  • [24] Second-Trimester Medical Abortion with Misoprostol Preceded by Two Sequential Doses of Mifepristone: An Observational Study
    Usham Shantikumar
    Rashmi Bagga
    Jasvinder Kalra
    Vanita Jain
    Vanita Suri
    Anju Singh
    Neelam Choudhary
    The Journal of Obstetrics and Gynecology of India, 2022, 72 : 26 - 35
  • [25] Efficacy of Single Dose of Mifepristone Combined with Two Doses of Misoprostol in Early Medical Abortions
    Aarti Umranikar
    Sameer Umranikar
    Journal of Reproduction and Contraception, 2010, (01) : 35 - 40
  • [26] Mifepristone and misoprostol for early abortion when no gestational sac is present
    Schaff, EA
    Fielding, SL
    Eisinger, S
    Stadalius, L
    CONTRACEPTION, 2001, 63 (05) : 251 - 254
  • [27] Two mifepristone doses and two intervals of misoprostol administration for termination of early pregnancy: a randomised factorial controlled equivalence trial
    von Hertzen, H.
    Piaggio, G.
    Wojdyla, D.
    Marions, L.
    My Huong, N. T.
    Tang, O. S.
    Fang, A. H.
    Wu, S. C.
    Kalmar, L.
    Mittal, S.
    Erdenetungalag, R.
    Horga, M.
    Pretnar-Darovec, A.
    Kapamadzija, A.
    Dickson, K.
    Anh, N. D.
    Tai, N. V.
    Tuyet, H. T. D.
    Peregoudov, A.
    BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY, 2009, 116 (03) : 381 - 389
  • [28] Acceptability and feasibility of 400 μg buccal misoprostol after 200 mg mifepristone for early medical abortion in Georgia
    Tsereteli, Tamar
    Chong, Erica
    Louie, Karmen
    Bokhua, Zaza
    Winikoff, Beverly
    EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE, 2016, 21 (05) : 367 - 371
  • [29] Two prophylactic medication approaches in addition to a pain control regimen for early medical abortion < 63 days' gestation with mifepristone and misoprostol: study protocol for a randomized, controlled trial
    Dragoman, Monica V.
    Grossman, Daniel
    Kapp, Nathalie
    Nguyen My Huong
    Habib, Ndema
    Duong Lan Dung
    Tamang, Anand
    REPRODUCTIVE HEALTH, 2016, 13 : 1 - 10
  • [30] Mobius syndrome in a neonate after mifepristone and misoprostol elective abortion failure
    Bos-Thompson, Marie-Andree
    Hillaire-Buys, Dominique
    Roux, Clarisse
    Faillie, Jean-Luc
    Amram, Daniel
    ANNALS OF PHARMACOTHERAPY, 2008, 42 (06) : 888 - 892